Evidence map›Paper›PMID 32144191›Full record

ArticleRNA (New York, N.Y.)2020

Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the

Evgeny B Pichkur, Alena Paleskava, Andrey G Tereshchenkov, Pavel Kasatsky, Ekaterina S Komarova, Dmitrii I Shiriaev, Alexey A Bogdanov, Olga A Dontsova, Ilya A Osterman, Petr V Sergiev and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Modulation of translational decoding by mNature communications · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Evgeny B Pichkur *Petersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute," Gatchina, 188300, Russia.
Alena Paleskava *Petersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute," Gatchina, 188300, Russia.
Andrey G TereshchenkovDepartment of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
Pavel KasatskyPetersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute," Gatchina, 188300, Russia.
Ekaterina S KomarovaDepartment of Bioengineering and Bioinformatics and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
Dmitrii I ShiriaevDepartment of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
Alexey A BogdanovDepartment of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
Olga A DontsovaDepartment of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
Ilya A OstermanDepartment of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
Petr V SergievDepartment of Chemistry and A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
Yury S PolikanovDepartments of Biological Sciences and Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois 60607, USA.ORCID 0000-0002-5064-0327
Alexander G MyasnikovPetersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute," Gatchina, 188300, Russia.
Andrey L KonevegaPetersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute," Gatchina, 188300, Russia.ORCID 0000-0003-0125-7150
Skolkovo Institute of Science and Technology · RULomonosov Moscow State University · RUPeter the Great St. Petersburg Polytechnic University · RUCentre National de la Recherche Scientifique · FRKurchatov Institute · RUPetersburg Nuclear Physics Institute · RUUniversity of Illinois Chicago · US

Funding

Molecular mechanisms of action of ribosome-targeting antibiotics.R01GM132302 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI POLIKANOV, YURY · 2019 to 2022
$1.3M
Structural basis of Erm-mediated macrolide resistanceR21AI137584 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MANKIN, ALEXANDER S, POLIKANOV, YURY · 2018 to 2019
$440k
NIAID NIH HHS R21 AI137584NIGMS NIH HHS R01 GM132302
6 · The paper itself

Abstract

Macrolides are one of the most successful and widely used classes of antibacterials, which kill or stop the growth of pathogenic bacteria by binding near the active site of the ribosome and interfering with protein synthesis. Dirithromycin is a derivative of the prototype macrolide erythromycin with additional hydrophobic side chain. In our recent study, we have discovered that the side chain of dirithromycin forms lone pair-π stacking interaction with the aromatic imidazole ring of the His69 residue in ribosomal protein uL4 of the

Indexed as

Anti-Bacterial AgentsCryoelectron MicroscopyErythromycinEscherichia coliModels, MolecularProtein BiosynthesisProtein Synthesis InhibitorsRibosomesRNA, Ribosomal, 23SAnti-Bacterial AgentsdirithromycinErythromycinProtein Synthesis InhibitorsRNA, Ribosomal, 23S70S ribosomeantibioticcryo-EMdirithromycininhibitormacrolidenascent peptide exit tunnel

Identifiers

PMID32144191
PMCPMC7266154
OpenAlexW3010554809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.